| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $714.0M | +6.9% |
| Cost of Revenue | $266.6M | +3.0% |
| R&D Expense | $84.7M | -11.1% |
| SG&A Expense | $93.2M | -3.8% |
| Operating Income | $97.6M | +91.0% |
| Interest Expense | $31.6M | -21.7% |
| Pre-tax Income | $70.6M | +166.7% |
| Income Tax | -$74.0M | -2100.7% |
| Net Income | $144.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $553.4M | +14.5% |
| Accounts Receivable | $1.30B | +8.5% |
| Current Assets | $1.88B | +10.5% |
| Total Assets | $3.16B | +10.8% |
| Current Liabilities | $1.84B | +23.1% |
| Long-term Debt | $556.1M | +0.4% |
| Total Liabilities | $2.24B | +7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $236.2M | +0.4% |
| Capital Expenditures | $70.5M | +115.0% |
| Investing Cash Flow | -$92.8M | -95.3% |
| Financing Cash Flow | -$75.1M | -159.8% |
| Free Cash Flow | $165.6M | -18.2% |
| +534.7% |
| EPS (Basic) | $1.01 | +531.3% |
| EPS (Diluted) | $0.95 | +493.7% |
| Stockholders' Equity |
| $922.4M |
| +20.1% |